Bioventix (BVXP LN)

Bioventix specializes in the development and commercial supply of high-affinity sheep monoclonal antibodies (SMAs) for use in immunodiagnostics, particularly in clinical diagnostics and drugs of abuse testing. These antibodies are beneficial for detecting targets present at low concentrations or small molecules. The company is headquartered in Farnham, Surrey, UK, and was founded in 2003.